Skip to main content
. 2018 Oct 25;320(19):2010–2019. doi: 10.1001/jama.2018.15870

Figure 3. Effect of Lanreotide and Standard Care Compared With Standard Care Only on Estimated Glomerular Filtration Rate (eGFR) in Patients With Autosomal Dominant Polycystic Kidney Disease.

Figure 3.

The effect of lanreotide on slope of eGFR decline during the treatment phase according to prespecified baseline subgroups. htTKV indicates height-adjusted total kidney volume.